$23.20
+1.07(4.84%)
Mkt Cap $2.4B
$11.93
$63.66
52-Week Range
At A Glance
1
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modali...
2
Revenue is primarily driven by Pmo Products (60%) and Elevidys (40%).
3
Most recently: . Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On February (2026-02-25).
$2.4B
Market Cap
$2.2B
Revenue
-$715M
Net Income
Employees1,372
Fundamentals
How The Business Makes Money
Revenue by Segment
Pmo Products60%($5.8B)
Elevidys40%($3.8B)
Revenue by Geography
US90.4%($4.3B)
Non Us9.6%($462M)
Activity
What Changed Recently
Analyst View
Company Profile
CIK0000873303
ISINUS8036071004
CUSIP803607100
Phone617 274 4000
Address215 First Street, Cambridge, MA, 02142, US
SEC EDGAR